No Surprises Act – Part II Interim Final Rule
Oct 1, 2021
The No Surprises Act, passed as part of the Consolidated Appropriations Act, 2021 (CAA), includes prohibitions on certain “surprise” balance bills for:
The Act gives health care providers and health plans instructions on how to protect patients from these surprise balance bills, including:
In July 2021 regulators published an interim final rule seeking public comment, which we reviewed here. This provided vital details on which specific services/providers/facilities are covered, how to determine QPAs, and sample notices. However, that guidance had stipulated it was only Part I among several, and that details on the federal IDR process, patient protections through transparency and the patient-provider dispute resolution process, price comparison tools, and air ambulance reporting would be forthcoming this year, while other details might wait until much later (such as ID cards, provider directories, etc.).
In August 2021, regulators delayed certain CAA transparency effective dates, which we reviewed here. Numerous provisions were not delayed, however, so plans and providers are expected to comply in good faith with those, even if further guidance comes after this year or doesn’t come at all.
On Friday, September 10, 2021, regulators announced a notice of proposed rulemaking (NPRM) seeking public comment on the new air ambulance reporting required under section 106 of the No Surprises Act. “The NPRM proposes that plans, issuers, and providers of air ambulance services submit data for each air ambulance claim and transport for the two years covered by the reporting requirements in the No Surprises Act.” They also addressed enforcement mechanisms, including the ability to impose penalties of up to $10,000 per violation when air ambulance service providers fail to comply with the rules/prohibitions of the No Surprises Act or when providers or plans fail to provide reporting required under the Act. A couple weeks later on September 28, FAIR Health released a report of private and Medicare air ambulance claims, revealing that utilization is up, average charges increased well over 20% in the last four years, and other helpful statistics.
On Thursday, September 30, 2021, regulators announced Part II guidance on the No Surprises Act, also in the form of an interim final rule seeking public comment due to the constrained time to get rules implemented for January 1, 2022. They also announced the creation of a new “website focused primarily on providing general information about No Surprises Act provisions” which will include a federal portal for providers and plans to participate in the federal IDR process. Below is a summary of the Part II provisions we believe employers are likely to find most relevant.
The Part II guidance also provides a helpful table of IDR deadlines as follows.
IDR Action | Timeline |
Initiate 30-business-day open negotiation period | 30 business days, starting on the day of initial payment or notice of denial of payment |
Initiate independent dispute resolution process following failed open negotiation | 4 business days, starting the business day after the open negotiation period ends |
Mutual agreement on certified independent dispute resolution entity selection | 3 business days after the independent dispute resolution initiation date |
Departments select certified independent dispute resolution entity in the case of no conflict-free selection by parties | 6 business days after the independent dispute resolution initiation date |
Submit payment offers and additional information to certified independent dispute resolution entity | 10 business days after the date of certified independent dispute resolution entity selection |
Payment determination made | 30 business days after the date of certified independent dispute resolution entity selection |
Payment submitted to the applicable party | 30 business days after the payment determination |
IMA will continue to monitor regulator guidance and offer meaningful, practical, timely information.
This material should not be considered as a substitute for legal, tax and/or actuarial advice. Contact the appropriate professional counsel for such matters. These materials are not exhaustive and are subject to possible changes in applicable laws, rules, and regulations and their interpretations.